Revlimid Podcasts This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Curative Strategy for High-Risk Smoldering Myeloma (GEM-CESAR)
: Carfilzomib, Lenalidomide and Dexamethasone (KRd) As Induction Followed By HDT-ASCT, Consolidation with Krd and Maintenance with Rd ... Author: InternationalMyelomaFoundation Added: 01/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 16, 2018 Category: Cancer & Oncology Source Type: podcasts

Daratumumab in Combination with Carfilzomib, Lenalidomide, and Dex (KRd) in Pts with NDMM
Daratumumab (DARA) in Combination with Carfilzomib, Lenalidomide, and Dexamethasone (KRd) in Patients with Newly Diagnosed Multiple Myeloma (MMY1001): Updated Results from an Open-Label, Phase 1b Stud... Author: InternationalMyelomaFoundation Added: 01/16/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 16, 2018 Category: Cancer & Oncology Source Type: podcasts

Phase II Study in Multiple Myeloma Combination of Lenalidomide-Elotuzumab
Robert Z. Orlowski, MD, from MD Anderson Cancer Center discusses the phase II study in multiple myeloma and the combination of Lenalidomide-Elotuzumab at the 2017 American Society of Hematology. Author: ASHReport Added: 01/15/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 15, 2018 Category: Cancer & Oncology Source Type: podcasts

Multiple Myeloma studies for 2018 Data from Daratumumab with carfilzomib, lenalidomide etc
Robert Z. Orlowski, MD, PhD, from The University of Texas MD Anderson Cancer Center discusses multiple myeloma studies for 2018 data from daratumumab with carfilzomib, lenalidomide etc at the 2017 Ame... Author: ASHReport Added: 01/11/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 11, 2018 Category: Cancer & Oncology Source Type: podcasts

Combinations Well Tolerated in Multiple Myeloma Benefits are better when compared to lenalidomide alone
Robert Z. Orlowski, MD, PhD, from The University of Texas MD Anderson Cancer Center discusses combinations well tolerated in multiple Myeloma and that benefits are better when compared to lenalidomide... Author: ASHReport Added: 01/10/2018 (Source: Oncology Tube)
Source: Oncology Tube - January 10, 2018 Category: Cancer & Oncology Source Type: podcasts

ASPIRE trial for MM: updates from ASH 2017
The ongoing Phase III ASPIRE trial (NCT01080391) comparing carfilzomib, lenalidomide and dexamethasone (CRd) vs. lenalidomide and dexamethasone (Rd) in patients with relapsed multiple myeloma (MM) has... Author: VJHemOnc Added: 12/18/2017 (Source: Oncology Tube)
Source: Oncology Tube - December 18, 2017 Category: Cancer & Oncology Source Type: podcasts

Optimal use of lenalidomide as therapy for MDS
In this presentation from the 2017 European Focus on Myeloproliferative Neoplasms and Myelodysplastic Syndromes, Dr. Aristoteles Giagounidis discusses the optimal use of lanalidomide as therapy for my... Author: imedex Added: 10/19/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 19, 2017 Category: Cancer & Oncology Source Type: podcasts

Should I Discontinue Revlimid If I Remain MRD Negative?
Myeloma patients who have become MRD negative and are reassessing their treatment plan to prolong remission may wonder if its favorable to keep taking lenalidomide (Revlimid). Myeloma expert Dr. Gare... Author: patientpower Added: 10/09/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 9, 2017 Category: Cancer & Oncology Source Type: podcasts

ADD - What do you recommend if a patient experiences fatigue with Revlimid%2C Darzalex%2C and dex%3FWhat do you recommend if a patient experiences fatigue with Revlimid, Darzalex, and dex?
In this week's video, Dr. Brian GM Durie suggests ways to manage side effects if you are on a triplet combination. BOTTOM LINE: Make dose adjustments before stopping the combination of Rev, d... Author: InternationalMyelomaFoundation Added: 10/09/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 9, 2017 Category: Cancer & Oncology Source Type: podcasts

ADD - Is Kyprolis (carfilzomib) a treatment option for a first relapse of myeloma?
In this weeks video, Dr. Brian GM Durie talks about benefits and risks of the combination therapies of Kyprolis and dexamethasone (Kd), and Kyprolis, Revlimid, and dexamethasone (KRd). BOTTOM LINE... Author: InternationalMyelomaFoundation Added: 10/09/2017 (Source: Oncology Tube)
Source: Oncology Tube - October 9, 2017 Category: Cancer & Oncology Source Type: podcasts

ASCO 2017- Phase 3 ELOQUENT-2 study- Elotuzumab lenalidomide-dexamethasone vs Ld in relapsed-refractory MM
Background: Elotuzumab, an immunostimulatory monoclonal antibody, has a dual mechanism of action: directly activating NK cells and tagging myeloma cells for recognition/death via antibody-dependent ce... Author: InternationalMyelomaFoundation Added: 08/15/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2017 Category: Cancer & Oncology Source Type: podcasts

ASCO 2017- CALGB-ECOG 100104 Alliance study- Lenalidomide vs placebo maintenance after stem cell transplant
Background: At a prespecified interim analysis (Dec 2009), the phase 3 CALGB study results surpassed the prespecified superiority boundary (significantly improved PFS for LEN maint vs PBO after SCT) a... Author: InternationalMyelomaFoundation Added: 08/15/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 15, 2017 Category: Cancer & Oncology Source Type: podcasts

How Can I Keep Taking My Myeloma Medication and Avoid Getting a Rash?
As part of our Ask the Expert series, a viewer asks, Im doing well on Revlimid (lenalidomide), but the treatment has caused a rash. How can I keep taking it and avoid getting a rash? Dr. Hearn Ja... Author: patientpower Added: 07/20/2017 (Source: Oncology Tube)
Source: Oncology Tube - July 21, 2017 Category: Cancer & Oncology Source Type: podcasts

Can pomalidomide be effective salvage therapy for multiple myeloma patients progressing on lenalidomide?
David S. Siegel, MD, PhD of John Theurer Cancer Center discusses the use of pomalidomide for multiple myeloma patients progressing on lenalidomide. This was recorded at the 2017 ASCO Annual Meeting in... Author: obr Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts

Is combining pembrolizumab and lenalidomide effective when managing multiple myeloma patients?
David S. Siegel, MD, PhD of John Theurer Cancer Center discusses the combination of pembrolizumab and lenalidomide for treating patients with multiple myeloma at the 2017 ASCO Annual Meeting in Chicag... Author: obr Added: 06/22/2017 (Source: Oncology Tube)
Source: Oncology Tube - June 22, 2017 Category: Cancer & Oncology Source Type: podcasts